Streptavidin-conjugated anti-Drosophila primary antibodies are specialized affinity-purified monoclonal or polyclonal antibodies designed for highly sensitive detection of Drosophila melanogaster targets. By combining antibody specificity with streptavidin’s exceptional affinity for biotin, these reagents provide robust signal amplification across multiple assay platforms.

Key Features

• Ultra-high affinity: Streptavidin binds biotin with extraordinary strength, ensuring stable and reliable detection.
• Enhanced sensitivity: The tetrameric structure offers multiple biotin-binding sites, increasing avidity and signal intensity.
• Reduced background: Direct conjugation minimizes cross-reactivity and simplifies experimental workflows.
• Broad compatibility: Supports biotinylated antibodies, nucleic acid probes, peptides, enzymes, and fluorophores.

Applications

These antibodies are validated for Western blotting, immunohistochemistry, immunofluorescence, flow cytometry, ELISA, multiplex assays, and detection of biotinylated DNA or RNA probes. They are widely used to study developmental markers, neural proteins, cytoskeletal components, signaling molecules, histone modifications, and tagged proteins in Drosophila research.

Advantages

Compared with traditional biotin-secondary systems, streptavidin-conjugated primaries enable faster protocols, improved sensitivity for low-abundance targets, streamlined multiplexing, and reduced serum-derived cross-reactivity.